AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,272 | -18.2% | 186 | 0.0% | 0.00% | – |
Q4 2022 | $5,223 | +4.5% | 186 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 186 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 186 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | -16.7% | 186 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | -33.3% | 186 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -10.0% | 186 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | 0.0% | 186 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | +25.0% | 186 | +1.6% | 0.00% | – |
Q4 2020 | $8,000 | -90.2% | 183 | -89.3% | 0.00% | – |
Q4 2019 | $82,000 | -99.8% | 1,709 | -99.8% | 0.00% | -100.0% |
Q3 2019 | $35,113,000 | -34.8% | 1,083,694 | +0.4% | 0.04% | -29.8% |
Q2 2019 | $53,862,000 | -8.4% | 1,079,829 | +23.8% | 0.06% | -10.9% |
Q1 2019 | $58,822,000 | +47.9% | 872,225 | +1.1% | 0.06% | +23.1% |
Q4 2018 | $39,779,000 | -23.1% | 862,715 | +28.7% | 0.05% | -7.1% |
Q3 2018 | $51,705,000 | -2.0% | 670,443 | +7.0% | 0.06% | -1.8% |
Q2 2018 | $52,779,000 | +10.9% | 626,603 | +7.6% | 0.06% | +1.8% |
Q1 2018 | $47,607,000 | – | 582,141 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |